Taking its temperature, CBRE found slight cooling in the US life sciences sector, with vacancy rising, but still well above pre-pandemic levels.
At the same time, venture capital funding declined by 29 percent in the third quarter from the second, though funding volume remains on course for the third-highest annual total on record after 2021 and 2020.
Matt Gardner, CBRE Americas Life Sciences Leader, said in prepared remarks, "Life sciences real estate is a valuable asset. It's important to keep in mind that the pandemic set a new floor for the life sciences industry. Funding remains at high levels, and job growth continues.
Want to continue reading?
Become a Free ALM Digital Reader.
Once you are an ALM Digital Member, you’ll receive:
- Breaking commercial real estate news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical coverage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
*May exclude premium content© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
